"Cell-Free Nucleic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleic acids (DNA or RNA) found circulating in SERUM; PLASMA; or other BODY FLUIDS.
|Cell-Free Nucleic Acids
- Cell-Free Nucleic Acids
- Cell Free Nucleic Acids
- Nucleic Acids, Cell-Free
- Circulating Cell-Free Nucleic Acids
- Circulating Cell Free Nucleic Acids
- Circulating Nucleic Acids
- Acids, Circulating Nucleic
- Nucleic Acids, Circulating
- Cell-Free Nucleic Acid
- Cell Free Nucleic Acid
- Nucleic Acid, Cell-Free
- Cell-Free DNA
- Cell Free DNA
- DNA, Cell-Free
- Cell-Free Deoxyribonucleic Acid
- Acid, Cell-Free Deoxyribonucleic
- Cell Free Deoxyribonucleic Acid
- Deoxyribonucleic Acid, Cell-Free
- Circulating DNA
- DNA, Circulating
- Cell-Free RNA
- Cell Free RNA
- RNA, Cell-Free
- Cell-Free Ribonucleic Acid
- Acid, Cell-Free Ribonucleic
- Cell Free Ribonucleic Acid
- Ribonucleic Acid, Cell-Free
- Circulating RNA
- RNA, Circulating
Below are MeSH descriptors whose meaning is more general than "Cell-Free Nucleic Acids".
Below are MeSH descriptors whose meaning is more specific than "Cell-Free Nucleic Acids".
This graph shows the total number of publications written about "Cell-Free Nucleic Acids" by people in this website by year, and whether "Cell-Free Nucleic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cell-Free Nucleic Acids" by people in Profiles.
cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA. Nat Protoc. 2023 05; 18(5):1563-1583.
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial. Clin Cancer Res. 2023 02 16; 29(4):784-790.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 12; 29(Suppl 3):616-617.
Cell-free Nucleic Acids in Cancer: Current Approaches, Challenges, and Future Directions. Clin Lab Med. 2022 Dec; 42(4):669-686.
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. 2023 03; 83(3):200-209.
Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer. Nat Commun. 2022 09 29; 13(1):5566.
Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma. J Hematol Oncol. 2022 08 16; 15(1):106.
cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution. Clin Cancer Res. 2022 05 02; 28(9):1841-1853.
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review. JCO Precis Oncol. 2022 02; 6:e2100337.
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.